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Full-length fusion (F) glycoprotein of human respiratory syncytial virus (HRSV) and a truncated anchorless mutant lacking
the C-terminal 50 amino acids were expressed from vaccinia recombinants and purified by immunoaffinity chromatography
and sucrose gradient centrifugation. Electron microscopy of full-length F protein in the absence of detergents revealed
micelles, (i.e., rosettes) containing two distinct types of protein rods, one cone-shaped and the other lollipop-shaped. Analysis
of membrane anchorless F molecules indicated that they were similar to the cone-shaped rods and that rosettes, which they
formed on storage, were made up of lollipop-shaped rods. The two forms of F protein may represent different structures that
the molecule may adopt before and after activation for its role in membrane fusion. Studies of complexes of these structures
with monoclonal antibodies of known specificity provide information on the three-dimensional organization of antigenic sites
on the F protein and confirm the oligomeric structure, possibly trimeric, of both full-length F and membrane anchorless F.
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Human respiratory syncytial virus (HRSV) encodes two
major surface glycoproteins (G and F) that are incorpo-
rated in the virus particles. The attachment protein (G)
mediates virus binding to the cell receptor (Levine et al.,
1987), whereas the fusion (F) protein promotes fusion of
the viral and cell membranes at the initial stages of the
infectious cycle (Walsh and Hruska, 1983). The F protein
also promotes fusion of the membrane of infected cells
with that of adjacent cells to form characteristic syncytia.
A third small glycoprotein (SH) is encoded by HRSV that
is expressed abundantly at the surface of infected cells
but is incorporated only in small amounts in the virus
particle (Olmsted and Collins, 1989). The significance of
SH for the infectious cycle is unknown, except that this
protein induces membrane permeability changes (Pe´rez
et al., 1997) and enhances membrane fusion, when co-
expressed with F and G (Heminway et al., 1994).
The F protein of HRSV shares structural features and
limited, but significant, amino acid sequence identity
with F glycoproteins of other paramyxoviruses. It is syn-
thesized as an inactive precursor of 574 amino acids (F0)
(Gruber and Levine, 1983) that is cotranslationally glyco-
sylated on asparagines in the endoplasmic reticulum,
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122where it assembles into homo-oligomers (Collins and
Mottet, 1991). The F0 precursor is cleaved by subtilisin-
like proteases into two polypeptide chains (F2 N-terminal
to F1) before reaching the cell surface, probably in the
trans-Golgi network (Collins and Mottet, 1991). The F2
and F1 chains remain covalently linked by a disulfide
bond(s).
There are three hydrophobic sequences in the F
polypeptide. The first is the signal peptide, located at the
N-terminus of the F2 chain (amino acids 1 to 22), that is
removed from the mature glycoprotein. The second is the
fusion peptide at the N-terminus of the F1 chain (F1
residues 1 to 19) and the third is near the C-terminus of
F1, the transmembrane region (F1 residues 389–414).
The N-terminal third of the F1 chain is partially resistant
to proteases (Lo´pez et al., 1990) and several a-helices,
ncluding a coiled-coil heptad repeat (HRA), are pre-
icted to occur in this region (Lo´pez et al., 1998). Two of
he predicted a-helices, linked by a turn, were found in a
21-residue peptide analog (F1 residues 118–138) by NMR
(Toiron et al., 1996). Following the a-helical region, a
region of b-sheet that contains 11 closely spaced cys-
eine residues is predicted. The segment of F1 preceding
he C-terminal transmembrane region also contains a
eptad repeat (HRB).
Several laboratories have reported the isolation of
onoclonal antibodies (MAbs) against the F protein of
RSV (Beeler and van Wyke Coelingh, 1989; Garcı´a-
arreno et al., 1989; O¨rvell et al., 1987). Some of these
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123ELECTRON MICROSCOPY OF HRSV GLYCOPROTEINantibodies neutralize virus infectivity and inhibit mem-
brane fusion. Competition between antibodies for bind-
ing to virus identified three or four antigenic sites.
Epitopes recognized by the antibodies have been
mapped on the F primary structure by assaying their
binding to synthetic peptides (Bourgeois et al., 1991;
Arbiza et al., 1992; Trudel et al., 1987; Lo´pez et al., 1993)
or protein fragments expressed in bacteria (Martı´n-Gal-
FIG. 1. Analysis of purified F protein. The full-length (FWT) and the
membrane-anchorless (FTM2) forms of HRSV F glycoprotein were puri-
fied by immunoaffinity chromatography as indicated under Materials
and Methods. The purified proteins were analyzed by SDS–PAGE and
stained with Coomassie blue (A) or transferred to membranes and
visualized with a F1 chain-specific monoclonal antibody (47F) by West-
ern blot (B). Molecular mass markers, expressed in kDa, are indicated
on the right. The location of full-length and anchorless F1 chains is
indicated on the left.lardo et al., 1991; Naval et al., 1997) or, more frequently,
by sequencing escape mutants selected by growing the
were sedimented in a sucrose gradient as described under Materials and M
nd Western blot with antibody 47F.virus in the presence of individual monoclonal antibodies
(Arbiza et al., 1992; Lo´pez et al., 1998). Using these
methods, two major antigenic regions recognized by
neutralizing antibodies were located on F1, one preced-
ing the cysteine rich-region (site II) and the other near
the C-terminus of the cysteine cluster (sites IV, V, and VI)
(Lo´pez et al., 1998). In addition, an antigenic site recog-
nized by weakly neutralizing MAbs (site I) was mapped in
the middle of the cysteine-rich region (Lo´pez et al., 1998).
To obtain information on the structure and antigenicity
of HRSV F protein we have studied by electron micros-
copy (EM) complexes of MAbs of defined specificity with
preparations of purified protein. Two forms of purified F
were used in these studies, a full-length molecule and a
membrane anchorless protein. Our results indicate that
both preparations of F are oligomeric and that the differ-
ent antibodies bind to distinct sites. We discuss these
observations in relation to the primary structure of F and
the three-dimensional structures of the molecules re-
vealed by EM.
RESULTS
Purification of soluble and membrane-associated
forms of the F protein
Hep-2 cells were infected with either VAC-FWT, which
expresses full-length HRSV F protein at the cell surface,
or VAC-FTM
2 , which expresses a form of F that lacks the
-terminal 50 amino acids and is secreted into the cul-
ure medium. Full-length F was purified from detergent
xtracts of VAC-FWT-infected cells by immunoaffinity
chromatography followed by sucrose gradient centrifu-
gation. Soluble membrane anchorless F was purified
from culture supernatants of VAC-FTM2-infected cells, by
the same procedure but in the absence of detergent.
SDS–PAGE followed by Coomassie blue staining or
Western blotting, using an anti-F1 antibody, revealed theFIG. 2. Sucrose gradient centrifugation of full-length F and membrane anchorless F. The two forms of F, purified by immunoaffinity chromatography,
ethods. Aliquots of each fraction (25 ml) were analyzed by SDS–PAGE
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124 CALDER ET AL.presence of a major band corresponding to the F1 chain,
which migrated slightly faster in the case of membrane
anchorless F than full-length F (Fig. 1). In the case of
full-length F, low-molecular-weight bands that reacted
with the anti-F1 antibody correspond to previously char-
acterized degradation products of F1 (Lo´pez et al., 1990).
ther bands migrating less than F1 and reacting with the
nti-F1 antibody were observed in both full-length F and
embrane anchorless F. They may represent differently
lycosylated forms of F1 or uncleaved F0 polypeptides. A
and migrating near the bottom of the gel, which was
tained with Coomassie but did not react with 47F, may
epresent the F2 chain.
Density gradient centrifugation of full-length F and
embrane anchorless F in the presence of 1% octyl-
lucoside indicated that both proteins sedimented as
omogeneous bands near the top of a 10–30% sucrose
radient (Fig. 2). Without detergent, full-length F sedi-
ented as a broad band with aggregates that sedi-
ented toward the bottom of the gradient; membrane
nchorless F sedimented to the same position in the
resence or in the absence of detergent and a small
mount of this material also aggregated.
FIG. 3. Electron microscopy of purified F. One field of full-length F (A
(i) and the other with some rosettes (ii), are shown. Examples of rosette
End views of molecules are depicted in the bottom row.
FIG. 4. Diagram of the F protein primary structure and location o
represented, indicating the hydrophobic regions (black rectangles), the
the glycosylation sites (), and the location of antigenic sites. Shown
F1 chains (residues 1–438) and the number of amino acids of the F0 pre
anchorless F molecule, denoting dimensions as measured by EM. (C)
F rosette with three cone-shaped and three lollipop-shaped rods. The
monomers corresponding to cone-shaped and lollipop-shaped structu
lollipop-shaped molecule is indicated. The location of the N-terminus (
the center of the rosette in the lollipop-shaped structure. C9 denotes the C-te
full-length F is drawn for both cone and lollipop conformations.Electron microscopy of full-length F and membrane
anchorless F
Immunoaffinity-purified full-length F from the peak
fraction of the sucrose gradient without detergent (frac-
tion 6) was analyzed by negative stain EM (Fig. 3). It was
mainly in the form of rosettes, similar to those observed
for other full-length virus membrane glycoproteins (Wri-
gley et al., 1986) and described for the F glycoproteins of
other paramyxoviruses (Scheid et al., 1972; Hosaka and
Shimizu, 1972). The molecules in the rosettes were either
inverted cone-shaped or lollipop-shaped rods with their
wider ends projecting away from the centers of the
rosettes. About 70% of the rods appeared to be cone-
shaped; 30% were lollipop-shaped. The length of both
types of rod measured to the center of the rosette was 19
nm and the width of their wider ends was 6 nm. The
length of both rods projected from the central portion of
the rosette, the ectodomain, was 16 nm. The stem of the
lollipop-shaped rods measured 10 nm (Fig. 4). End views
of the rods that appeared to be triangular were also
seen, which is consistent with full-length F being a tri-
mer.
Electron microscopy of membrane anchorless F from
o fields of membrane anchorless F (B), one with individual molecules
dividual molecules are shown below with diagrams of their structures.
pes in lollipop-shaped structures. (A) The primary structure of F is
repeats (HRA and HRB, shaded rectangles), the cysteine residues (F),
ottom are the number of amino acids of the F2 (residues 1–136) and
at the bottom (residues 1–574). (B) Shape of an individual cone-shaped
lollipop-shaped rods of anchorless F forming a rosette. (D) Full-length
of antigenic sites is shown. (E) Models of the F1 chain in anchorless
e antiparallel orientation of HRA and HRB in the monomer from the
e cone-shaped rod is unknown but it is postulated that it relocates to) and twf epito
heptad
at the b
cursor
Three
location
res. Th
N) in th
rminus of the anchorless F. (F) Similarly, the F1 chain monomer of the
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126 CALDER ET AL.the peak fraction of the gradient without detergent (frac-
tion 4) revealed predominantly individual cone-shaped
rods that were not associated with one another (Fig. 3).
The dimensions of the rods were indistinguishable from
those in rosettes of full-length F, except that their length
was about 16 nm, the same as that of the ectodomain
(Fig. 4). End views of membrane anchorless F were also
triangular. In some preparations variable amounts of
membrane anchorless F were seen to form rosettes. By
contrast with full-length F rosettes, however, at least 90%
of the rods in the membrane anchorless rosettes were
FIG. 5. Electron microscopy of F antibodies 2F, 47F, and 56F comp
membrane anchorless F (right) bound to the indicated antibodies (left-
at the bottom of each panel.lollipop-shaped; on forming rosettes, the soluble cone-
shaped rods appeared to become lollipop-shaped.Monoclonal antibody–F complexes
Rosettes of full-length F and soluble membrane an-
chorless F preparations were incubated with monoclonal
antibodies representative of antibodies that recognize
three distinct regions in the primary structure of F and
the complexes were analyzed by EM (Fig. 5).
Antibody 2F, which does not react with escape mu-
tants with amino acid changes at residue 253 of the F1
chain (antigenic site I), was seen to bind at the top of the
wide distal end of full-length F rods in the rosettes (Fig.
to F protein. Fields and selected examples of full-length F (left) and
argin) are shown. Drawings of the F–antibody complexes are shownlexed5). In some cases, 2F bound to two neighboring rods of
the same rosette or to two rods from two different ro-
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127ELECTRON MICROSCOPY OF HRSV GLYCOPROTEINsettes, cross-linking the rosettes, and two antibody mol-
ecules were seen to cross-link rosettes by each combin-
ing with the same two rods, one from each rosette. The
angle made between the Fab regions and the F rods was
the same (150°) irrespective of these orientations, as
observed previously in antibody–antigen complexes
(Wrigley et al., 1983b). Antibody 2F also bound at the top
f membrane anchorless F rods and the angle of binding
as also 150°. Again, two antibodies bound to two an-
horless F rods (212 complexes) were frequently seen
nd 313 and greater complexes were also seen.
Antibody 47F, which does not react with escape mu-
ants with changes at residues 126, 132, 136, and 139 of
he F1 chain (antigenic site II), was seen to bind to the
ase of the head region of both full-length F and mem-
rane anchorless F at an angle of 85–90°. When com-
lexed with full-length F, antibody 47F was most fre-
uently seen binding to two rods from the same rosette
nd each rod was able to bind at least two Fab regions
rom different antibody molecules (Fig. 5). When bound to
embrane anchorless F, antibody 47F bound at the
ame position and angle as to the rosettes, and a variety
f types of complexes were seen due to the inherent
lexibility of the antibody molecules. However, 212 com-
lexes were not observed.
Antibody 56F, which does not react with escape mu-
ants with a single change at residue 293 of the F1 chain
antigenic site IV), bound at an angle of about 95–100° to
he side of the F rods, not quite at the end projected from
he center of the rosettes (Fig. 5). The binding site and
he angle were the same for full-length and anchorless
olecules, irrespective of the shape of the rods (cones
r lollipops). Antibodies cross-linking adjacent rods in a
osette and others cross-linking two rosettes were again
een.
Other antibodies recognizing antigenic sites I, II, and
V were also studied for interaction with full-length F (Fig.
). Antibodies 44F and 45F (antigenic site I) generated
tructures like those for 2F, and the binding angle was
50° for all three antibodies. Antibody M13 (antigenic site
I) bound to the base of the heads of F rods with an angle
f 85–90°, like antibody 47F. Antibody M19 (antigenic site
V) bound to the side of the heads of the rods in a similar
osition and at the same angle as 56F. These results are
n agreement with the classification of antibodies based
n reactivity with escape mutants (Arbiza et al., 1992;
o´pez et al., 1998).
Two other antibodies whose epitopes have been lo-
ated near antigenic site IV in the F primary structure
ere also studied. Antibody 7.957 (antigenic site V),
hich does not recognize escape mutants with changes
t residues 296, 297, or 311, bound to the side of the
eads of the F rosettes at an angle of 110–115°. Antibody
.916 (antigenic site VI), which does not react with mu-
ants with changes at residue 300 (Lo´pez et al., 1998),
lso bound at this position at an angle of 120°. Thebinding characteristics of antibodies 7.957 and 7.916
were the same in the full-length and anchorless F mol-
ecules. These results confirmed the conclusion from
sequence analysis of antigenic variants that antigenic
sites IV, V, and VI are located close together in the F
molecule and provide evidence that the antibodies used
to distinguish them have different binding properties.
DISCUSSION
Membrane anchorless HRSV F, expressed in recom-
binant vaccinia-infected cells, appears to be secreted as
stable oligomers that are cone-shaped rods with a length
of 16 nm and a width, at the base of the cones, of 6 nm
(Fig. 4B). Views of the rods on end indicate a triangular
cross section, suggesting that they are trimers. On pro-
longed storage (e.g., 8 weeks at 4°C) an increasing
number of rosettes form in these preparations and at
least 90% of the rods in the rosettes are morphologically
distinguishable from the cone-shaped soluble rods. They
are instead lollipop-shaped, similar in length to the sol-
uble rods but containing distinct spherical heads on thin
stems, at the other ends of which the rods associate to
form the rosettes (Fig. 4C). The mechanism of conversion
of the soluble rods to rosettes is not known but it is
possible that the hydrophobic fusion peptide may be-
come exposed on storage and that its exposure results
in rosette formation and changes in rod morphology.
Our studies of antibody binding to the soluble rods and
the rosettes that they form shed little light on the nature
of the differences in their structures. The antibodies
recognize distinct sites on the heads of the lollipops,
binding at characteristic angles with them. They appear
to bind in the same ways to the cone-shaped soluble
rods and in the same relative positions (Fig. 5). Individual
rods of both types are seen to combine with at least two
antibodies, consistent with the conclusion that they are
oligomeric.
Examination of the rosette structures formed by re-
moval of detergent from full-length F suggests that they
are heterogeneous with about 70% of the rods being
cone-shaped and the remainder being lollipop-shaped
(Fig. 4D). Perhaps storage of full-length F can lead to
changes in morphology similar to those seen for soluble
membrane anchorless F. Both types of rods project their
wider ends from the centers of the rosettes, indicating
that the hydrophobic membrane anchor regions are at
the opposite, narrower ends. Since these purified ro-
settes were not aggregated with one another, it seems
that the hydrophobic region of membrane anchorless F
that associates to form rosettes is not available in full-
length F rosettes to cause interrosette association and
may be located together with the membrane anchor
region in the centers of these full-length F rosettes (Fig.
4F). End views of the full-length F rods in the rosettes
also suggested that they were trimers. The properties of
es of r
d formed
128 CALDER ET AL.the antibody complexes formed by the rosetted full-
length F molecules were indistinguishable from those
formed by membrane anchorless F.
Although the sequence of HRSV F protein has limited
identity (,20%) with the F glycoproteins of other
paramyxoviruses, there are structural features that are
shared by all these proteins (review by Morrison and
Portner, 1991). Secondary structure predictions indicate
the presence in the F1 chain of HRSV F of two a-helix-
containing heptad repeats, HRA, residues 20–63 of F1,
and HRB, residues 353–377 of F1. These motifs are
conserved in all paramyxovirus F glycoproteins (Cham-
bers et al., 1992). X-ray crystallography of complexes
formed by these regions of the SV5 F protein indicates
that HRA forms a trimeric coiled-coil core and that three
a-helices formed by HRB are packed antiparallel against
it (Baker et al., 1999). The length of this six-helix struc-
FIG. 6. Complexes of antibodies with full-length F rosettes. Exampl
epicted. The antigenic sites to which antibodies bind and the angleture, 10 nm, is similar to that of the stems of the lollipop-
shaped rods described here. The possibility that thefusion peptide is responsible for rosette formation by
anchorless F, as indicated in Fig. 4E, and that on expo-
sure in full-length F it relocates to the center of the
rosettes (Fig. 4F) also indicates that the fusion peptide
and the membrane anchor would be antiparallel to each
other. In the sequence of F, HRA and HRB are separated
by approximately 300 amino acids. That these residues
form the lollipop heads is indicated by the antibody-
binding properties of the head regions.
Figure 4 shows the locations of the proposed anti-
body-binding sites in the F primary structure and on a
lollipop-shaped rod seen by EM. The location of anti-
genic site II (residues 126, 132, 136, and 139 of F1) near
HRA in the primary structure and at the base of the head
as determined by EM, is consistent with the possibility
that HRA is in the stem of the rods. Similarly, antigenic
sites IV, V, and VI (residues 293, 296, 297, 300, and 311),
osettes with bound antibodies (indicated in the left-hand margin) are
by the antibody and the axis of the F rods are indicated on the left.located at the sides of the heads as determined by EM,
are closer to HRB in the primary structure than antigenic
b
g
p
p
a
w
u
m
u
P
o
o
t
o
m
u
g
e
e
o
p
c
t
d
m
a
w
c
2
s
t
F
E
t
d
u
p
(
w
p
3
a
2
i
s
S
l
P
s
T
4
c
129ELECTRON MICROSCOPY OF HRSV GLYCOPROTEINsite I (residue 253 of F1), which, as determined by EM, is
at the tip of the molecule. These orientations are consis-
tent with the possibility that the lollipop stems are formed
of antiparallel HRA and HRB as observed by X-ray crys-
tallography of peptide complexes of SV5 F protein (Baker
et al., 1999).
It is considered likely, by comparison with the struc-
tures of other membrane fusion molecules (Skehel and
Wiley, 1998) and from the results of experiments in which
peptide analogues of HRA and HRB inhibit fusion activity
(Joshi et al., 1998), that the six-helix structure of
paramyxovirus fusion glycoproteins is formed from an as
yet undescribed structure on activation of the F glyco-
protein’s fusion potential. An obvious possible conclu-
sion from this study is that the cone-shaped rods repre-
sent the preactivated structure of F and that the lollipops
are postactivation structures. If this proves to be the
case, the structural change in F on fusion activation
would occur independent of the receptor-binding protein
(for review see Lamb, 1993).
MATERIALS AND METHODS
Cells and viruses
Recombinant vaccinia viruses expressing the full-
length F protein of HRSV (VAC-FWT) or a mutated F protein
lacking the C-terminal 50 amino acids (VAC-FTM2) have
een described (Bembridge et al., 1999). Briefly, the F
ene of HRSV Long strain was subcloned from LF1
lasmid (Cristina et al., 1990) into StuI–HindIII-cleaved
RB21 vector that carries the VP37 vaccinia gene (Blasco
nd Moss, 1995), to obtain VAC-FWT. A premature stop
codon was introduced into the LF1 plasmid by PCR
mutagenesis to eliminate the last 50 amino acids of the
F protein and then it was subcloned again into pRB21 to
obtain VAC-FTM2. CV-1 cells were infected with the vac-
cinia strain vRB12 and then transfected with pRB21-
derived plasmids. Since vRB12 lacks the VP37 gene and
thus is unable to form plaques, recombinant viruses
could be readily recovered from the supernatant of in-
fected/transfected cells by plaquing in susceptible CV-1
cells. Isolated plaques were recovered and plaqued
again two or three more times to ensure the homogene-
ity of the virus stocks.
HEp-2 cells were grown in Dulbecco’s medium sup-
plemented with 10% fetal calf serum, as previously de-
scribed (Garcı´a-Barreno et al., 1988). They were infected
ith the vaccinia recombinants (m.o.i. of 5 PFU/cell)
sing medium without serum and 48 h later the cells and
edium were collected separately and kept frozen until
se.
urification of monoclonal antibodies and preparation
f immunoaffinity columnsMAbs used in this study have been described previ-
usly (Garcı´a-Barreno et al., 1989; O¨rvell et al., 1987;
t
WTaylor et al., 1992). Antibodies were purified from mouse
ascitic fluid by protein A–Sepharose chromatography
(Garcı´a-Barreno et al., 1989) and dialyzed against car-
bonate buffer (0.1 M NaHCO3, pH 8.3, 0.5 M NaCl). Eight
o 10 mg of purified 2F antibody (IgG1) was bound to 1 g
f CNBr-activated Sepharose (Pharmacia) following the
anufacturer’s instructions. Unreacted groups were sat-
rated with 0.1 M Tris–HCl, pH 8.0, 0.5 M NaCl, and the
el was used for preparation of a 5-ml column that was
quilibrated with phosphate-buffered saline (PBS). Differ-
nt columns of 2F-Sepharose were used for purification
f FWT and FTM2 to avoid cross-contamination.
Purification of full-length F and membrane
anchorless F
Hep-2 cells infected with VAC-FWT were used for the
urification of the full-length F as follows: 1 vol of frozen
ell pellet was resuspended in 10 vol of PBS that con-
ained 1% octyl-glucoside and vortexed thoroughly. Cell
ebris was separated by centrifugation at 10,000g for 15
in and the supernatant was loaded onto a monoclonal
ntibody 2F-Sepharose column. The column was
ashed with 20 vol of PBS. The material retained in the
olumn was eluted with 10 vol of 0.1 M glycine–HCl, pH
.5, and immediately neutralized with saturated Tris. Ab-
orbance at 280 nm was used to follow protein content
hroughout the purification process. The presence of the
protein in the column fractions was assessed by
LISA. Fractions containing the F protein were pooled
ogether, concentrated with Centricon 30 (Amicon), and
ialyzed against a large excess of PBS.
Culture supernatants of VAC-FTM2-infected cells were
sed for the purification of the soluble form of the F
rotein. Supernatants were centrifuged at low speed
2000g) to eliminate cell debris. Then, ammonium sulfate
as added slowly to 65% saturation and the protein
recipitate was collected by centrifugation at 10,000g for
0 min. The pellet was resuspended and dialyzed
gainst PBS. Finally, the solution was loaded onto a
F-Sepharose column that was washed and eluted as
ndicated above. The purity of FWT and FTM2 was as-
essed by SDS–PAGE (Fig. 1).
ucrose gradient centrifugation
Proteins eluted from the 2F-Sepharose columns were
oaded onto a preformed 10–30% sucrose gradient in
BS. In some cases 1% octyl-glucoside was added to the
amples and the gradient contained 1% octyl-glucoside.
he samples were centrifuged at 34,000 rpm for 15 h at
°C in a SW40 rotor. Thirteen one-milliliter fractions were
ollected from the top of the tubes. Twenty-five microli-ers of each fraction was analyzed by SDS–PAGE and
estern blot with the monoclonal antibody 47F.
a
P
1
M
p
(
B
B
B
B
B
C
C
C
G
G
G
H
H
J
L
L
L
L
L
M
M
N
O
O
P
S
S
130 CALDER ET AL.Electron microscopy
F protein samples in PBS were absorbed onto car-
bon films and stained with 1% sodium silicotungstate
(pH 7.0). A Jeol 1200 electron microscope, operated at
100 kV, was used to view the samples. Micrographs
were taken under minimum-dose, accurate defocus
conditions to preserve details to ;1.5 nm (Wrigley et
al., 1983a).
ACKNOWLEDGMENTS
We thank G. Taylor for antibodies M13 and M19 and C. O¨rvell for
ntibodies 7.957 and 7.916. This work was supported in part by Grant
M96-0025 from Ministerio de Educacio´n y Cultura and Grant 98/
086 from Fondo de Investigaciones Sanitarias to J.A.M. and by the
edical Research Council to J.J.S. and L.C. L.G. was recipient of a
redoctoral fellowship from Ministerio de Educacio´n y Ciencia
Spain).
REFERENCES
Arbiza, J., Taylor, G., Lo´pez, J. A., Furze, J., Wyld, S., Whyte, P., Stott,
E. J., Wertz, G., Sullender, W., Trudel, M., and Melero, J. A. (1992).
Characterisation of two antigenic sites recognised by neutralising
monoclonal antibodies directed against the fusion glycoprotein of
human respiratory syncytial virus. J. Gen. Virol. 73, 2225–2234.
aker, K. A., Dutch, R. E., Lamb, R. A., and Jardetzky, T. S. (1999).
Structural basis for paramyxovirus-mediated membrane fusion. Mol.
Cell 3, 309–319.
eeler, J. A., and van Wyke Coelingh, K. (1989). Neutralising epitopes of
the F glycoprotein of respiratory syncytial virus: Effect of mutation
upon fusion function. J. Virol. 63, 2941–2950.
embridge, G. P., Lo´pez, J. A., Bustos, R., Melero, J. A., Cook, R., Mason,
H., and Taylor, G. (1999). Priming with a secreted form of the fusion
protein of respiratory syncytial virus (RSV) promotes interleukin-4
(IL-4) and IL-5 production but not pulmonary eosinophilia following
RSV challenge. J. Virol. 73, 10086–10094.
lasco, R., and Moss, B. (1995). Selection of recombinant vaccinia
viruses on the basis of plaque formation. Gene 158, 157–162.
ourgeois, C., Corvaisier, C., Bour, J. B., Kohli, E., and Pothier, P. (1991).
Use of synthetic peptides to locate neutralizing antigenic domains in
the fusion protein of respiratory syncytial virus. J. Gen. Virol. 72,
1051–1058.
hambers, P., Pringle, C. R., and Easton, A. J. (1992). Sequence
analysis of the gene encoding the fusion glycoprotein of pneumo-
nia virus of mice suggests possible conserved secondary struc-
ture elements of paramyxovirus fusion glycoproteins. J. Gen. Virol.
73, 1717–1724.
ollins, P. L., and Mottet, G. (1991). Post-translational processing and
oligomerisation of the fusion glycoprotein of human respiratory syn-
cytial virus. J. Gen. Virol. 72, 3095–3101.
ristina, J., Lo´pez, J. A., Albo, C., Garcı´a-Barreno, B., Melero, J. A., and
Portela, A. (1990). Analysis of genetic variability in human respiratory
syncytial virus by the RNase A mismatch cleavage method. Virology
174, 126–134.
arcı´a-Barreno, B., Jorcano, J. L., Aukenbauer, T., Lo´pez-Galı´ndez, C.,
and Melero, J. A. (1988). Participation of cytoskeletal intermediate
filaments in the infectious cycle of human respiratory syncytial virus
(RSV). Virus Res. 9, 307–322.
arcı´a-Barreno, B., Palomo, C., Pen˜as, C., Delgado, T., Perez-Bren˜a, P.,
and Melero, J. A. (1989). Marked differences in the antigenic structure
of human respiratory syncytial virus F and G glycoproteins. J. Virol.
63, 925–932.
ruber, C., and Levine, S. (1983). Respiratory syncytial virus polypep-tides. III. The envelope-associated proteins. J. Gen. Virol. 64, 825–
832.
eminway, B. R., Yu, Y., Tanaka, Y., Perrine, K. G., Gustafson, E.,
Bernstein, J. M., and Galinski, S. (1994). Analysis of respiratory
syncytial virus F, G and SH protein in cell fusion. Virology 200,
801–805.
osaka, Y., and Shimizu, Y. (1972). Artificial assembly of envelope
particles of HVJ (Sendai virus). I. Assembly of hemolytic and fusion
factors from envelopes solubilised by Nonidet P40. Virology 49,
627–639.
oshi, S. B., Dutch, R. E., and Lamb, R. A. (1998). A core trimer of the
paramyxovirus fusion protein: Parallels to influenza virus hemagglu-
tinin and HIV-1 gp41. Virology 248, 20–34.
amb, R. B. (1993). Paramyxovirus fusion: A hypothesis for changes.
Virology 197, 1–11.
evine, S., Klaiber-Franco, R., and Paradiso, P. R. (1987). Demonstration
that glycoprotein G is the attachment protein of respiratory syncytial
virus. J. Gen. Virol. 68, 2521–2524.
o´pez, J. A., Pen˜as, C., Garcı´a-Barreno, B., Melero, J. A., and Portela, A.
(1990). Location of a highly conserved neutralising epitope in the F
glycoprotein of human respiratory syncytial virus. J. Virol. 64, 927–
930.
o´pez, J. A., Andreu, D., Carren˜o, C., Whyte, P., Taylor, G., and
Melero, J. A. (1993). Conformational constraints of conserved
neutralising epitopes from a major antigenic area of human re-
spiratory syncytial virus fusion glycoprotein. J. Gen. Virol. 74,
2567–2577.
o´pez, J. A., Bustos, R., O¨rvell, C., Berois, M., Arbiza, J., Garcı´a-Barreno,
B., and Melero, J. A. (1998). Antigenic structure of human respiratory
syncytial virus fusion glucoprotein. J. Virol. 72, 6922–6928.
artı´n-Gallardo, A., Flen, K. A., Hu, B. T., Farly, J. F., Collins, P. L.,
Hildreth, S. W., and Paradiso, P. R. (1991). Expression of the F
glycoprotein gene from human respiratory syncytial virus in Esche-
richia coli: Mapping of a fusion inhibiting epitope. Virology 184,
428–432.
orrison, T., and Portner, A. (1991). Structure, function and intracellular
processing of the glycoproteins of Paramyxoviridae. In “The
Paramyxovirus” (D. W. Kingsbury, Eds.), pp. 347–382. Plenum, New
York.
aval, J., Pin˜ol, J., Rebordosa, X., Serra-Hartmann, X., Perez-Pons, J. A.,
and Querol, E. (1997). Expression in Escherichia coli and purification
of soluble forms of the F protein of bovine respiratory syncytial virus.
Protein Expr. Purif. 9, 288–294.
lmsted, R. A., and Collins, P. L. (1989). The 1A protein of respiratory
syncytial virus is an integral membrane protein present as multiple,
structurally distinct species. J. Virol. 63, 2019–2029.
¨ rvell, C., Norrby, E., and Mufson, M. (1987). Preparation and charac-
terisation of monoclonal antibodies directed against five structural
components of human respiratory syncytial virus subgroup B. J. Gen.
Virol. 68, 3125–3135.
e´rez, M., Garcı´a-Barreno, B., Melero, J. A., Carrasco, L., and Guinea, R.
(1997). Membrane permeability changes induced in Escherichia coli
by the SH protein of human respiratory syncytial virus. Virology 235,
342–351.
cheid, A., Caliguiri, L. A., Compans, R. W., and Choppin, P. N. (1972).
Isolation of paramyxovirus glycoproteins. Association of both hem-
agglutinin and neuraminidase activities with the larger SV5 glyco-
protein. Virology 50, 640–652.
kehel, J. J., and Wiley, D. C. (1998). Coiled coils in both intracellular
vesicle and viral membrane fusion. Cell 95, 871–874.
Taylor, G., Stott, E. J., Furze, J., Ford, J., and Sopp, P. (1992). Protective
epitopes of the fusion protein of respiratory syncytial virus recog-
nized by murine and bovine monoclonal antibodies. J. Gen. Virol. 73,
2217–2223.
Toiron, C., Lo´pez, J. A., Rivas, G., Andreu, D., Melero, J. A., and Bruix,
M. (1996). Conformational studies of a short linear peptide corre-
sponding to a major conserved neutralising epitope of human
W131ELECTRON MICROSCOPY OF HRSV GLYCOPROTEINrespiratory syncytial virus fusion glycoprotein. Biopolymers 39,
537–548.
Trudel, M., Nadon, F., Seguin, C., Dionne, C., and Lacroix, M. (1987).
Identification of a synthetic peptide as part of a major neutralisation
epitope of respiratory syncytial virus. J. Gen. Virol. 68, 2273–2280.
Walsh, E. E., and Hruska, J. (1983). Monoclonal antibodies to respiratory
syncytial virus proteins: Identification of the fusion protein. J. Virol. 47,
171–177.
Wrigley, N. G., Brown, E. B., and Chillingworth, R. K. (1983a). Combiningaccurate defocus with low-dose imaging in high resolution electron
microscopy of biological material. J. Microsc. 130, 225–232.
Wrigley, N. G., Brown, E. B., and Skehel, J. J. (1983b). Electron micro-
scopic evidence for the axial rotation and inter-domain flexibility of
the Fab regions of immunoglobulin G. J. Mol. Biol. 169, 771–774.
rigley, N. G., Brown, E. B., and Skehel, J. J. (1986). Electron microscopy
of influenza virus. In “Electron Microscopy of Proteins, Vol. 5, Viral
Structure” (J. R. Harris and R. W. Horne, Eds.), pp. 103–163. Academic
Press, London.
